UPDATED Oct 03, 2025
Explore the Global Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
PXMD | US$0.0001 | 0% | -99.9% | US$12.6k | n/a | PE-0.0007x | n/a | n/a | ||
CANF | ₪0.01 | 0% | -61.5% | ₪47.3m | n/a | PS25.5x | n/a | n/a | ||
OPGN | US$0.0001 | 0% | -100.0% | US$1.0k | n/a | PE0.00009x | n/a | n/a | ||
LDP | ₫12,200.00 | 0% | -26.1% | ₫162.7b | n/a | PE22.2x | n/a | 0% | ||
8158 | HK$0.70 | 0% | 183.4% | HK$213.0m | n/a | PE168x | n/a | n/a | ||
6810 | NT$24.10 | 0% | -28.9% | NT$1.2b | n/a | n/a | n/a | n/a | ||
6541 | NT$52.50 | 0% | -22.3% | NT$12.5b | n/a | PS112.9x | n/a | n/a | ||
239 | HK$2.40 | 0% | 0% | HK$747.9m | n/a | PE10.5x | n/a | 7.7% | ||
4132 | NT$12.00 | 0% | -33.5% | NT$1.9b | n/a | PS43.7x | n/a | n/a | ||
DHT | ₫84,000.00 | 0% | 17.8% | ₫6.9t | n/a | PE94.8x | n/a | 1.2% | ||
ATX | AU$0.17 | 0% | 10.0% | AU$84.7m | n/a | PS22.4x | S54.2% | n/a | ||
MBCI | US$0.0001 | 0% | n/a | US$78.1k | n/a | n/a | n/a | n/a | ||
6955 | HK$12.59 | 0% | 31.6% | HK$7.8b | HK$10.44 | PE223.8x | S33.9% | n/a | ||
539267 | ₹18.20 | 0% | -16.2% | ₹414.0m | n/a | PB3.4x | n/a | n/a | ||
HLTT | US$0.0001 | 0% | n/a | US$10.7k | n/a | n/a | n/a | n/a | ||
MRRC.F | US$0.000001 | 0% | 0% | US$237.0 | n/a | n/a | n/a | n/a | ||
311A | JP¥1,200.00 | 0% | n/a | JP¥5.8b | n/a | n/a | n/a | n/a | ||
BSSP | US$0.000001 | 0% | n/a | US$4.1k | n/a | n/a | n/a | n/a | ||
A001360 | ₩1,595.00 | 0% | -12.7% | ₩150.1b | n/a | PE11.8x | n/a | n/a | ||
PXYN | US$0.000001 | 0% | n/a | US$847.0 | n/a | n/a | n/a | n/a | ||
BBM | CA$0.015 | 0% | 0% | CA$7.4m | n/a | PS16.9x | n/a | n/a | ||
CALI.X | CA$0.005 | 0% | n/a | CA$5.0m | n/a | PE-15.1x | n/a | n/a | ||
IVRN | US$0.0002 | 0% | n/a | US$1.6k | n/a | n/a | n/a | n/a | ||
A377740 | ₩5,800.00 | 0% | 26.6% | ₩587.9b | n/a | PE4.9x | n/a | 3.4% |